Lynx1 Capital Management LP - 30 Jun 2025 SCHEDULE 13G Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CGEM
Shares outstanding: 58,677,893 shares
Disclosed Ownership: 4,400,842 shares
Ownership: 7.5%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 06:58:39 UTC
Date of event: 30 Jun 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	7.5%	4,400,842	0	4,400,842	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	7.5%	4,400,842	0	4,400,842	/s/ Weston Nichols	Weston Nichols, Individually